Oxidoreductase, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | yes | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 7 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AHY5
Term | Name | Level | Count |
---|---|---|---|
GO:0006950 | response to stress | 2 | 8 |
GO:0006979 | response to oxidative stress | 3 | 8 |
GO:0009987 | cellular process | 1 | 8 |
GO:0033554 | cellular response to stress | 3 | 8 |
GO:0034599 | cellular response to oxidative stress | 4 | 8 |
GO:0042221 | response to chemical | 2 | 8 |
GO:0050896 | response to stimulus | 1 | 8 |
GO:0051716 | cellular response to stimulus | 2 | 8 |
GO:0062197 | cellular response to chemical stress | 4 | 8 |
GO:0070887 | cellular response to chemical stimulus | 3 | 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 8 |
GO:0016491 | oxidoreductase activity | 2 | 8 |
GO:0016651 | oxidoreductase activity, acting on NAD(P)H | 3 | 8 |
GO:0016657 | oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor | 4 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 42 | 44 | PF00675 | 0.295 |
CLV_PCSK_KEX2_1 | 41 | 43 | PF00082 | 0.297 |
CLV_PCSK_PC1ET2_1 | 41 | 43 | PF00082 | 0.371 |
CLV_PCSK_SKI1_1 | 190 | 194 | PF00082 | 0.379 |
CLV_PCSK_SKI1_1 | 97 | 101 | PF00082 | 0.355 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.579 |
DOC_MAPK_MEF2A_6 | 77 | 85 | PF00069 | 0.323 |
DOC_PP4_FxxP_1 | 193 | 196 | PF00568 | 0.332 |
DOC_USP7_MATH_1 | 206 | 210 | PF00917 | 0.355 |
DOC_USP7_MATH_1 | 218 | 222 | PF00917 | 0.521 |
DOC_USP7_MATH_1 | 28 | 32 | PF00917 | 0.576 |
DOC_USP7_UBL2_3 | 137 | 141 | PF12436 | 0.323 |
DOC_USP7_UBL2_3 | 97 | 101 | PF12436 | 0.295 |
LIG_14-3-3_CanoR_1 | 219 | 227 | PF00244 | 0.465 |
LIG_14-3-3_CanoR_1 | 22 | 28 | PF00244 | 0.407 |
LIG_Actin_WH2_2 | 88 | 103 | PF00022 | 0.295 |
LIG_BRCT_BRCA1_1 | 31 | 35 | PF00533 | 0.433 |
LIG_FHA_1 | 78 | 84 | PF00498 | 0.323 |
LIG_FHA_2 | 102 | 108 | PF00498 | 0.355 |
LIG_FHA_2 | 64 | 70 | PF00498 | 0.396 |
LIG_LIR_Gen_1 | 197 | 207 | PF02991 | 0.371 |
LIG_LIR_Nem_3 | 197 | 202 | PF02991 | 0.355 |
LIG_SH2_SRC | 130 | 133 | PF00017 | 0.371 |
LIG_SH2_STAP1 | 146 | 150 | PF00017 | 0.389 |
LIG_SUMO_SIM_anti_2 | 58 | 64 | PF11976 | 0.284 |
LIG_SUMO_SIM_anti_2 | 78 | 85 | PF11976 | 0.279 |
LIG_SUMO_SIM_par_1 | 58 | 64 | PF11976 | 0.284 |
LIG_TRAF2_1 | 104 | 107 | PF00917 | 0.355 |
LIG_WRC_WIRS_1 | 150 | 155 | PF05994 | 0.371 |
MOD_CK1_1 | 154 | 160 | PF00069 | 0.355 |
MOD_CK1_1 | 5 | 11 | PF00069 | 0.607 |
MOD_CK2_1 | 101 | 107 | PF00069 | 0.317 |
MOD_CK2_1 | 52 | 58 | PF00069 | 0.355 |
MOD_CK2_1 | 63 | 69 | PF00069 | 0.355 |
MOD_GlcNHglycan | 157 | 160 | PF01048 | 0.297 |
MOD_GlcNHglycan | 166 | 169 | PF01048 | 0.299 |
MOD_GlcNHglycan | 17 | 20 | PF01048 | 0.600 |
MOD_GlcNHglycan | 31 | 34 | PF01048 | 0.418 |
MOD_GSK3_1 | 151 | 158 | PF00069 | 0.314 |
MOD_GSK3_1 | 17 | 24 | PF00069 | 0.590 |
MOD_GSK3_1 | 2 | 9 | PF00069 | 0.580 |
MOD_GSK3_1 | 37 | 44 | PF00069 | 0.245 |
MOD_N-GLC_1 | 116 | 121 | PF02516 | 0.299 |
MOD_NEK2_1 | 15 | 20 | PF00069 | 0.516 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.415 |
MOD_PIKK_1 | 151 | 157 | PF00454 | 0.371 |
MOD_PIKK_1 | 50 | 56 | PF00454 | 0.299 |
MOD_PKA_1 | 101 | 107 | PF00069 | 0.355 |
MOD_PKA_1 | 41 | 47 | PF00069 | 0.355 |
MOD_PKA_2 | 21 | 27 | PF00069 | 0.424 |
MOD_PKA_2 | 218 | 224 | PF00069 | 0.482 |
MOD_PKA_2 | 41 | 47 | PF00069 | 0.308 |
MOD_Plk_1 | 116 | 122 | PF00069 | 0.429 |
MOD_Plk_4 | 123 | 129 | PF00069 | 0.295 |
MOD_Plk_4 | 77 | 83 | PF00069 | 0.323 |
MOD_SUMO_rev_2 | 107 | 116 | PF00179 | 0.355 |
MOD_SUMO_rev_2 | 209 | 218 | PF00179 | 0.478 |
TRG_DiLeu_BaEn_1 | 197 | 202 | PF01217 | 0.355 |
TRG_ENDOCYTIC_2 | 181 | 184 | PF00928 | 0.295 |
TRG_NES_CRM1_1 | 183 | 198 | PF08389 | 0.355 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IAF5 | Leptomonas seymouri | 64% | 100% |
A0A3Q8IWH0 | Leishmania donovani | 99% | 100% |
A4HQ99 | Leishmania braziliensis | 74% | 100% |
C9ZSG5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
E9AU17 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
P37261 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 30% | 100% |
Q4Q0H8 | Leishmania major | 94% | 100% |
Q96VH4 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 34% | 100% |